Liver Cancer Cell Lines
Database

LCCL to predict drug response

Drug: Dasatinib

DrugsAliasTargetsTargeted cellular functionClinical status in any tumor typeClinical status in HCCSupplierReference
Dasatinib BMS-354825 SRC, ABL Tyrosine kinases Approved Phase 2 Selleck Chemicals S1021

Cell Line (34)
Cell LineAUCGI50
JHH10.420.02
HepaRG0.490.06
Huh60.595.025
JHH40.60.145
HCC.1.20.630.285
Li70.660.73
SNU1820.681.48
B10.695.49
SNU4230.710.0
SNU8780.710.0
SNU3540.77.025
SNU7390.7110.0
SNU8860.740.78
HCC.1.10.742.48
JHH50.753.585


LCCL transcriptomic subgroup:
CL1
CL2
CL3
undef.

Codebase Soc. Coop.
info@codebase.it